CELC PEER ANALYSIS

Celcuity LLC — metric-by-metric comparison with peers and the industry median

CELCCelcuity LLC

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

CELCIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	CELC	TLX	MSB	CSL	Ind. Median
P/E	—	—	—	30.02	17.81
P/B	110.48	6.56	—	2.24●	3.49
EV/EBITDA	—	123.31	—	10.37●	14.92
P/S	38,399.83	3.34	31.91	2.67●	10.89

Financial Health
Metric	CELC	TLX	MSB	CSL	Ind. Median
Current Ratio	12.31●	1.43	—	2.57	5.90
Debt/Equity	365.4%	112.3%	—	67.4%●	10.9%
NetDebt/EBITDA	-0.29●	13.13	—	2.22	1.15

Profitability
Metric	CELC	TLX	MSB	CSL	Ind. Median
Net Margin	-125,250.6%	-0.9%	-115.3%	9.2%●	-125.7%
ROE	-275.2%	-1.8%	-11.3%	7.7%●	-47.5%
ROA	-61.4%	-0.7%	-8.6%	3.8%●	-35.8%
EBITDA Margin	-112,116.2%	3.0%	-76.6%	32.8%●	-105.8%

Growth + Dividend
Metric	CELC	TLX	MSB	CSL	Ind. Median
Rev. Growth	26.9%	56.3%	410.4%●	4.8%	5.1%
NI Growth	—	—	—	-39.4%	12.1%
Div. Yield	—	—	0.0%	2.5%●	0.2%
Payout	—	—	0.0%	103.1%	0.0%

Valuation
Metric	CELC	ERAS	LGND	ACLX	TVTX	PTCT	Ind. Median
P/E	—	—	41.49	-28.30●	—	—	17.81
P/B	110.48	14.58	6.39	16.10	53.49	-39.07●	3.49
EV/EBITDA	—	—	27.19	-30.94●	138.66	—	14.92
P/S	38,399.83	—	23.21	290.72	9.85	8.52●	10.89

Financial Health
Metric	CELC	ERAS	LGND	ACLX	TVTX	PTCT	Ind. Median
Current Ratio	12.31	9.52	21.28●	4.44	3.13	2.44	5.90
Debt/Equity	365.4%	11.7%	45.3%	23.9%	331.9%	-218.9%●	10.9%
NetDebt/EBITDA	-0.29	0.73	-1.47●	1.79	1.63	12.52	1.15

Profitability
Metric	CELC	ERAS	LGND	ACLX	TVTX	PTCT	Ind. Median
Net Margin	-125,250.6%	—	55.9%●	-1,027.3%	-4.0%	-22.6%	-125.7%
ROE	-275.2%	-69.9%	17.1%●	-53.4%	-32.6%	—	-47.5%
ROA	-61.4%	-59.4%	12.6%●	-34.8%	-3.9%	-6.8%	-35.8%
EBITDA Margin	-112,116.2%	—	81.0%●	-888.3%	7.2%	-14.5%	-105.8%

Growth + Dividend
Metric	CELC	ERAS	LGND	ACLX	TVTX	PTCT	Ind. Median
Rev. Growth	26.9%	-100.0%	51.2%	-79.4%	96.0%●	-53.3%	5.1%
NI Growth	—	—	—	—	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on CELC

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.